CTOs on the Move

Health Net

www.healthnet.com

 
Health Net is a publicly traded managed care organization that delivers managed health care services through health plans and government-sponsored managed care plans. Its mission is to help people be healthy, secure and comfortable. Health Net provides and administers health benefits to approximately 6.0 million individuals across the country through group, individual, Medicare (including the Medicare prescription drug benefit commonly referred to as “Part D”), Medicaid, dual eligible, U.S. Department of Defense, including TRICARE, and U.S. Department of Veterans Affairs programs. Health Net also offers behavioral health, substance abuse and employee assistance programs, and managed health care products related to ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

CG HEALTHCARE SOLUTIONS

CG HEALTHCARE SOLUTIONS is a Toms River, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heathrow Scientific

Heathrow Scientific is a Vernon Hills, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rapid Healthcare

Rapid Healthcare Inc is proud to offer the best in clinical mobility solutions. Our goal is simple: work with an existing hospital infrastructure, understand their workflow, and supercharge it with the power and convenience of clinical mobility. By empowering clinical mobile solutions, every aspect of the healthcare industry experiences greater efficiency at a lower cost. Our solutions and creativity will revolutionize healthcare from admissions to discharge.

Neotonus Inc

Neotonus Inc is a Marietta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III